drugset / Trial / NCT00153725

Intravenous Pantoloc In Aspirin-Induced Ulcer Bleeding

NCT00153725

Completed 156 enrolled Chinese University of Hong Kong
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to investigate whether intravenous infusion of pantoprazole (Pantoloc) is effective in preventing recurrent bleeding in patients who present with acute ulcer bleeding and continue to use aspirin

Timeline

Start
2003-02
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 80 mg
Background Pantoprazole Other / unclassified Intravenous